345 results
Page 10 of 18
8-K
v99ek6z
24 Aug 12
Bristol-Myers Squibb Discontinues Development of BMS-986094, an Investigational NS5B Nucleotide for the Treatment of Hepatitis C
12:00am
8-K
EX-99.1
se10ai8fqpiqurw
24 Aug 12
Bristol-Myers Squibb Discontinues Development of BMS-986094, an Investigational NS5B Nucleotide for the Treatment of Hepatitis C
12:00am
8-K
EX-99.1
sz640o6i
3 Aug 12
Bristol-Myers Squibb Suspends Administration of Study Drug in Clinical Trial of Investigational NS5B Nucleotide for the Treatment of Hepatitis C
12:00am
8-K
EX-4.1
1lhztm
31 Jul 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-4.2
ykge5qxyedrqm6rvd
31 Jul 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-4.4
wnaia9ms
31 Jul 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-4.3
eyrz420d3f77ptm1j5s
31 Jul 12
Entry into a Material Definitive Agreement
12:00am
424B5
3d7uss4r
27 Jul 12
Prospectus supplement for primary offering
12:00am
424B3
0xdljy
26 Jul 12
Prospectus supplement
12:00am
8-K
EX-2.1
an79w2u65yo crwk
3 Jul 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
4kvz5j zd
26 Jan 12
Net Sales Rise 7% to $5.5 Billion in Fourth Quarter
12:00am